What are the normal values for Creatine Kinase-MB (CKMB) and their units?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Values for CK-MB

The normal CK-MB value is defined as below the 99th percentile of a healthy reference population, with sex-specific reference limits required—typically CK-MB mass should be <5 ng/mL in most assays, though the exact cutoff varies by laboratory and must be established using at least 120 healthy individuals. 1

Reference Range Standards

  • The 99th percentile cutoff represents the upper limit of normal for CK-MB, and values exceeding this threshold suggest myocardial injury when accompanied by appropriate clinical context 1

  • Men typically have higher baseline CK-MB values than women due to greater muscle mass, making sex-specific reference limits mandatory in clinical practice 1

  • The assay's total imprecision (coefficient of variation) should be ≤10% at the 99th percentile reference limit to ensure reliable clinical decision-making 1

Units of Measurement

  • CK-MB is reported as CK-MB mass in ng/mL (nanograms per milliliter), which is the standard unit for modern immunoassays 2

  • Studies reference diagnostic thresholds ranging from ≥5 ng/mL to ≥8 ng/mL depending on the specific assay and clinical context 2

CK-MB Relative Index

  • The CK-MB relative index (CK-MB mass/total CK activity ratio) is expressed as ng/U (nanograms per unit of total CK activity) 3, 4

  • A CK-MB index >5.0 is diagnostic of myocardial infarction, while a value <3.0 virtually excludes this diagnosis 3

  • For differentiating myocardial necrosis from skeletal muscle injury, a ratio of ≥80 ng/U strongly indicates myocardial damage rather than muscular injury 4

  • The typical CK-MB index in myocardial infarction exceeds 200 ng/U, with most patients demonstrating at least one ratio ≥110 ng/U within 8-32 hours of symptom onset 4

Critical Clinical Context

  • Two consecutive measurements of CK-MB above the 99th percentile are required to establish sufficient biochemical evidence of myocardial necrosis 1

  • Serial measurements documenting a characteristic rise and/or fall pattern are essential to maintain diagnostic specificity and distinguish acute myocardial injury from chronic elevations or skeletal muscle sources 1

  • CK-MB begins to rise within 3-4 hours after myocardial injury onset and returns to normal within 24-72 hours 1, 5

Important Caveats

  • Total CK measurement alone is not recommended for diagnosing myocardial infarction due to poor specificity, as it is abundantly present in skeletal muscle 1

  • CK-MB can be elevated in skeletal muscle damage, particularly from diaphragm and other muscles, though the CK-MB/total CK ratio helps differentiate cardiac from skeletal muscle sources 4

  • In trauma and burn patients without myocardial involvement, maximum CK-MB mass/total CK activity ratios average 7-18 ng/U, with the highest ratio after muscular damage typically not exceeding 38 ng/U (except in rare cases) 4

References

Guideline

CK-MB Reference Values and Clinical Application

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Early Detection of Myocardial Infarction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.